CEACAM5 and cancer: Studies have shown that the carcinoembryonic antigen (CEA) tumor promoter can functionally replace the PRV IE180 promoter, and the recombinant PRV-CEA virus can preferentially replicate in different cancer cell lines, and PRV-CEA can additionally induce apoptosis type [41].